Brief: H Lundbeck: Supportive Phase Ii Results With LU AF82422 In Treatment Of Multiple System Atrophy

H Lundbeck A/S

31/01/2024 13:11

Jan 31 (Reuters) - H Lundbeck A/S  HLUNb.CO :
    * SIGNALS OF EFFICACY ACROSS CLINICAL AND BIOMARKER
ENDPOINTS IN A
SMALL EXPLORATORY PROOF-OF-CONCEPT TRIAL OF 61 MSA PATIENTS
    * TREND OF A SLOWING MSA PROGRESSION WAS OBSERVED IN GROUP
EXPOSED
TO LU AF82422

Source text for Eikon:  ID:nWkr5D6nM5 
Further company coverage:  HLUNb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))